SCHEMBL5449297

SCHEMBL5449297

Cc1cccc2cc(CN(Cc3cccnc3)S(=O)(=O)c3ccc4c(c3)OCCN4C)c(=O)[nH]c12

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.56
ALDH1A1 P00352 8/20 0.56
HSD17B10 Q99714 7/20 0.56
LMNA P02545 5/20 0.56
MAPK1 P28482 3/20 0.56
MAPT P10636 2/20 0.56
RECQL P46063 1/20 0.49
ADRB2 P07550 1/20 0.47
USP2 O75604 1/20 0.46
ALOX12 P18054 1/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.42
HPGD P15428 2/20 0.42
ALOX15 P16050 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5454157 0.92 ALDH1A1 (0.60) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL5449131 0.91 ALDH1A1 (0.60) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL5460816 0.87 KDM4E (0.61) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL5446708 0.86 KDM4E (0.59) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL5454245 0.85 KDM4E (0.60) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL4069417 0.85 KDM4E (0.58) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL5451674 0.84 HSD17B10 (0.79) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL5446964 0.84 KDM4E (0.59) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL5449313 0.84 KDM4E (0.58) KDM4EALDH1A1HSD17B10LMNAMAPK1
SCHEMBL4078124 0.84 ALDH1A1 (0.58) KDM4EALDH1A1HSD17B10LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US claimed
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof ABCG2, ATP5ME, ATP5MG KDM4E 2403/4885ALDH1A1 1055/4885HSD17B10 1580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.